With the intention of discovering effective and budget-friendly strategies for smooth clinical trial operations, industry leaders, oncology biotechs, and patient advocates will be gathering at the upcoming 13th Annual Clinical Trials in Oncology East Coast 2024 conference taking place on 9-10 July. The event will be held in Burlington, Massachusetts.
The conference will kick off with talks on the importance of communicating and incorporating patient perspectives to have smooth trial operations. Opening day will feature presentations and discussions on the best communication and collaboration practices that facilitate clinical technology implementation, site efficiency, and promote successful trial outcomes. Distributed throughout these sessions will be talks on how to navigate the changing regulatory, financial, and clinical trial landscape, with a session dedicated to discussing the US Food and Drug Administration’s (FDA) Project Optimus and early phase protocols.
Also centre stage on day 1 are discussions emphasising the role of diverse patients in driving innovative clinical trials, with a panel discussion highlighting patient centricity in clinical trial development and patient engagement.
The second day will kick off with interactive speaker-hosted roundtable discussions, which will provide conference attendees the option to join four roundtable discussions that focus on tackling the challenges in clinical trial operations throughout the conference.
A major topic of discussion on day 2 will be site operations, specifically, the partnerships, vendor relationships, and data management processes that drive success. Early in the day will be sessions highlighting the importance of balanced relationships and management principles in oncology clinical trials. The second day will also feature a panel discussion delineating how effective outsourcing strategies can keep trial costs within their allotted budgets and optimise the research ecosystem in trials.
The second day will end with a case study presenting challenges in Phase III oncology studies and the data and technology solutions that can be implemented to optimise these trials.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThe conference is hosted by Arena International Events Group, a B2B events company owned by GlobalData, the parent company of Clinical Trials Arena and Pharmaceutical Technology. A detailed agenda can be found here.